Drawing for FUJIREBIO NEURO CENTER OF EXCELLENCE

USPTO serial 79351939

FUJIREBIO NEURO CENTER OF EXCELLENCE

Reviewed by CopyMark Law Group

Reg. 7209639Status 700Registered
Filing date
Status date
Registration date
Nov 7, 2023
Examiner
PARKS, KIMBERLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FUJIREBIO NEURO CENTER OF EXCELLENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gabrielle S. Roth

Gabrielle S. Roth Sughrue Mion, PLLC2000 Pennsylvania Ave., NW, Suite 9000Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurology, and consulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testing, analysis and research for medical purposes in the field of neurology; scientific testing, analysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals; testing, inspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and development in the field of diagnostic preparations; providing information relating to medical research in the field of medicine, chemistry and diagnostics relating to neurology; providing information relating to medical research in the field of medicine, chemistry and diagnostics; working on and evaluation of chemical analyses in the field of neurology; working on and evaluation of chemical analyses; consultancy in the field of chemistry relating to neurology; consultancy in the field of chemistry; testing, inspection and research of chemicals and pharmaceuticals relating to chemistry in the field of neurology; testing, inspection and research of diagnostic agents relating to chemistry; testing, inspection, research, evaluation and analysis of chemical ingredients in the field of neurology; testing, inspection, research, evaluation and analysis of chemical ingredients; product research and development services; product development consultancy; providing quality assurance services in the field of neurology; quality assurance consultancy services in the field of neurology; product quality testing; material testing and analysis for product quality; testing the functionality of, and research on, machines, apparatus and instruments; testing the functionality of, and research relating to, medical apparatus and instruments in the field of neurology, and their parts; testing the functionality of, and research relating to, medical apparatus and instruments and their parts; design of medical apparatus and instruments in the field of neurology; design of medical apparatus and instruments; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus in the field of neurology; design and development of medical diagnostic apparatus; rental of laboratory apparatus for chemical substances in the field of neurology; rental of laboratory apparatus for chemical substances; rental of measuring apparatus; rental of measuring and laboratory machines and instruments; rental of laboratory apparatus and instruments; rental of computers; providing computer programs on data networks, namely, providing temporary use of online non-downloadable software for database management in the field of neurology; computer software design, computer programming, and maintenance of computer software; scientific and medical research and development in the field of neurology by collaborating with third parties; scientific and medical research and development by collaborating with third parties; scientific research, testing and analysis services by engineers and scientists, and their technological consultancy services in the field of neurology; pharmaceutical product evaluation by engineers and scientists, and its technological consultancy services; evaluation of chemical analyses by engineers and scientists, and its technological consultancy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 9, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 9, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 7, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 2, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 7, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 7, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 22, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 2, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 2, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jul 18, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 18, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 18, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 6, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 6, 2023RFRRREFUSAL PROCESSED BY MPU—
Apr 8, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2023DOCKASSIGNED TO EXAMINER—
Oct 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance